Using machine learning to identify patients with cancer that would benefit from immunotherapy
A new study examines the development of two machine learning models to classify the immunophenotype of a cancer specimen.
Apr 16, 2024
0
0
Mary Ann Liebert Inc. was founded in 1980 by Mary Ann Liebert in New Rochelle, NY. The company publishes peer-reviewed journals, books and trade magazines in a variety of fields. A sample of journals, include Genetic Engineering & Biotechnology News, Human Gene Therapy and Women's Health. BioConferences International Inc. is a subsidiary of Mary Ann Liebert Inc. This company's focus is to organize symposiums and conferences in Biotechnology, Women's Health, Alternative Medicine, Law and more.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
A new study examines the development of two machine learning models to classify the immunophenotype of a cancer specimen.
Apr 16, 2024
0
0
Two new review articles in AI in Precision Oncology explore the role of artificial intelligence (AI) in early cancer detection. A primer provides an overview of AI, and the second review examines the promising clinical applications ...
Apr 11, 2024
0
1
A new case report published in OMICS: A Journal of Integrative Biology describes how longitudinal multi-omics monitoring (LMOM) helped to detect a precancerous pancreatic tumor and led to a successful surgical intervention.
Apr 22, 2024
0
1